Lovastatin - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for lovastatin and what is the scope of patent protection?

Lovastatin is the generic ingredient in three branded drugs marketed by Covis, Actavis Elizabeth, Aurobindo Pharma Usa, Carlsbad, Chartwell Rx, Corepharma, Epic Pharma Llc, Lupin, Sun Pharm Industries, Teva, and Merck, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for lovastatin. Twenty-three suppliers are listed for this compound.

Summary for lovastatin

US Patents:	0
Tradenames:	3
Applicants:	11
NDAs:	12
Drug Master File Entries:	33
Finished Product Suppliers / Packagers:	23
Raw Ingredient (Bulk) Api Vendors:	124
Clinical Trials:	76
Patent Applications:	7,114
Drug Prices:	Drug price trends for lovastatin
Drug Sales Revenues:	Drug sales revenues for lovastatin
What excipients (inactive ingredients) are in lovastatin?	lovastatin excipients list
DailyMed Link:	lovastatin at DailyMed

See drug prices for lovastatin

Drug Sales Revenue Trends for lovastatin

See drug sales revenues for lovastatin

Recent Clinical Trials for lovastatin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	N/A
AstraZeneca	Phase 4
Heart Health Research Center	Phase 4

See all lovastatin clinical trials

Pharmacology for lovastatin

Drug Class	HMG-CoA Reductase Inhibitor
Mechanism of Action	Hydroxymethylglutaryl-CoA Reductase Inhibitors

Medical Subject Heading (MeSH) Categories for lovastatin

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for lovastatin

C10AA	HMG CoA reductase inhibitors
C10A	LIPID MODIFYING AGENTS, PLAIN
C10	LIPID MODIFYING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for lovastatin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Usa	LOVASTATIN	lovastatin	TABLET;ORAL	075451-002	Dec 17, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	LOVASTATIN	lovastatin	TABLET;ORAL	075935-001	Dec 17, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Actavis Elizabeth	LOVASTATIN	lovastatin	TABLET;ORAL	075828-002	Dec 17, 2001	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	LOVASTATIN	lovastatin	TABLET;ORAL	075451-001	Dec 17, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for lovastatin

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	MEVACOR	lovastatin	TABLET;ORAL	019643-002	Mar 28, 1991	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-004	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-001	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-002	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.